Skin recruitment of monomyeloid precursors involves human herpesvirus-6 reactivation in drug allergy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 5, 2013, Pages 681-689

  Hashizume, H ^a   Fujiyama, T ^a   Kanebayashi, J ^a   Kito, Y ^a   Hata, M ^a   Yagi, H ^a  

^a SHIMADA MUNICIPAL HOSPITAL   (Japan)

Author keywords

CD4+ T lymphocyte; drug induced hypersensitivity syndrome; high mobility group box 1; human herpesvirus 6, monocyte

Indexed keywords

ALLOPURINOL; CARBAMAZEPINE; CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CHEMOKINE RECEPTOR CCR4; HIGH MOBILITY GROUP B1 PROTEIN; MEXILETINE; MICROSOMAL AMINOPEPTIDASE; MINOCYCLINE; PHENOBARBITAL; PHENYTOIN; SALAZOSULFAPYRIDINE; TRIBENOSIDE; ZONISAMIDE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL POPULATION; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA EXTRACTION; DRUG HYPERSENSITIVITY; ELECTRON MICROSCOPY; FEMALE; FLOW CYTOMETRY; GENOME; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOFLUORESCENCE; LYMPHOCYTIC INFILTRATION; MALE; MONOCYTE; MONOMYELOID PRECURSOR; MYELOID PROGENITOR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN INFILTRATE; VIRUS REACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; CD4-POSITIVE T-LYMPHOCYTES; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEMALE; HERPESVIRUS 6, HUMAN; HMGB1 PROTEIN; HUMANS; MALE; MIDDLE AGED; MYELOID PROGENITOR CELLS; PHENOTYPE; ROSEOLOVIRUS INFECTIONS; SKIN; VIRUS ACTIVATION;

EID: 84876676084     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12138     Document Type: Article

References (33)

1. Shiohara T, Inaoka M, Kano Y,. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006; 55: 1-8.
2. Hashimoto K, Yasukawa M, Tohyama M,. Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol 2003; 3: 255-260. (Pubitemid 37010880)
3. Shiohara T, Kano Y,. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol 2007; 33: 124-133. (Pubitemid 351514149)
4. Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 2007; 157: 934-940. (Pubitemid 47583515)
5. Hashizume H, Hansen A, Poulsen LK, Thomsen AR, Takigawa M, Thestrup-Pedersen K,. In vitro propagation and dynamics of T cells from skin biopsies by methods using interleukins-2 and -4 or anti-CD3/CD28 antibody-coated microbeads. Acta Derm Venereol 2010; 90: 463-473.
6. Elliott MJ, Vadas MA, Eglinton JM, Park LS, To LB, Cleland LG, et al. Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor show common biological effects and binding characteristics on human monocytes. Blood 1989; 74: 2349-2359. (Pubitemid 19286452)
7. Pozo F, Tenorio A,. Detection and typing of lymphotropic herpesviruses by multiplex polymerase chain reaction. J Virol Methods 1999; 79: 9-19. (Pubitemid 29182786)
8. Hashizume H, Takigawa M, Tokura Y,. Characterization of drug-specific T cells in phenobarbital-induced eruption. J Immunol 2002; 168: 5359-5368. (Pubitemid 34496005)
9. Hashizume H, Seo N, Ito T, Takigawa M, Yagi H,. Promiscuous interaction between gold-specific T cells and APCs in gold allergy. J Immunol 2008; 181: 8096-8102.
10. Hashizume H, Aoshima M, Ito T, Seo N, Takigawa M, Yagi H,. Emergence of circulating monomyeloid precursors predicts reactivation of human herpesvirus-6 in drug-induced hypersensitivity syndrome. Br J Dermatol 2009; 161: 486-488.
11. van Lochem EG, van der Velden VH, Wind HK, te Marvelde JG, Westerdaal NA, van Dongen JJ,. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts. Cytometry B Clin Cytom 2004; 60: 1-13. (Pubitemid 38885703)
12. Mollen KP, Levy RM, Prince JM, Hoffman RA, Scott MJ, Kaczorowski DJ, et al. Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrow-derived cells and parenchymal cells. J Leukoc Biol 2008; 83: 80-88.
13. Lotze MT, Tracey KJ,. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005; 5: 331-342. (Pubitemid 40516158)
14. Bianchi ME, Manfredi AA,. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 2007; 220: 35-46. (Pubitemid 350045574)
15. Palumbo R, Galvez BG, Pusterla T, De Marchis F, Cossu G, Marcu KB, et al. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation. J Cell Biol 2007; 179: 33-40. (Pubitemid 47606681)
16. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A,. HMGB1: endogenous danger signaling. Mol Med 2008; 14: 476-484.
17. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-251. (Pubitemid 29329996)
18. Nakajima S, Watanabe H, Tohyama M, Sugita K, Iijima M, Hashimoto K, et al. High-mobility group box 1 protein (HMGB1) as a novel diagnostic tool for toxic epidermal necrolysis and Stevens-Johnson syndrome. Arch Dermatol 2011; 147: 1110-1112.
19. Popovic K, Ek M, Espinosa A, Padyukov L, Harris HE, Wahren-Herlenius M, et al. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 2005; 52: 3639-3645. (Pubitemid 41612235)
20. Straino S, Di Carlo A, Mangoni A, De Mori R, Guerra L, Maurelli R, et al. High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol 2008; 128: 1545-1553. (Pubitemid 351693201)
21. Dockrell DH,. Human herpesvirus 6: molecular biology and clinical features. J Med Microbiol 2003; 52 (Pt 1): 5-18. (Pubitemid 36106363)
22. Lusso P, Malnati M, De Maria A, Balotta C, DeRocco SE, Markham PD, et al. Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J Immunol 1991; 147: 685-691.
23. Ancuta P, Liu KY, Misra V, Wacleche VS, Gosselin A, Zhou X, et al. Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets. BMC Genomics 2009; 10: 403.
24. Martinez FO,. The transcriptome of human monocyte subsets begins to emerge. J Biol 2009; 8: 99.
25. Gordon S, Taylor PR,. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964. (Pubitemid 41746764)
26. Platzer B, Jorgl A, Taschner S, Hocher B, Strobl H,. RelB regulates human dendritic cell subset development by promoting monocyte intermediates. Blood 2004; 104: 3655-3663. (Pubitemid 39564442)
27. Kondo K, Kondo T, Okuno T, Takahashi M, Yamanishi K,. Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 1991; 72 (Pt 6): 1401-1408.
28. Santangelo S, Gamelli RL, Shankar R,. Myeloid commitment shifts toward monocytopoiesis after thermal injury and sepsis. Ann Surg 2001; 233: 97-106. (Pubitemid 32042779)
29. Ishida Y, Gao JL, Murphy PM,. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 2008; 180: 569-579.
30. Livingston DH, Anjaria D, Wu J, Hauser CJ, Chang V, Deitch EA, et al. Bone marrow failure following severe injury in humans. Ann Surg 2003; 238: 748-753. (Pubitemid 38182268)
31. Kitamura K, Asada H, Iida H, Fukumoto T, Kobayashi N, Niizeki H, et al. Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash/graft-versus-host disease after allogeneic stem cell transplantation. J Am Acad Dermatol 2008; 58: 802-809.
32. Bellon T, Alvarez L, Mayorga C, Morel E, Torres MJ, Martin-Diaz MA, et al. Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases. Br J Dermatol 2010; 162: 1014-1022.
33. Tagami K, Yujiri T, Tanimura A, Mitani N, Nakamura Y, Ariyoshi K, et al. Elevation of serum high-mobility group box 1 protein during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilisation. Br J Haematol 2006; 135: 567-569. (Pubitemid 44583424)